Study On The Construction Of Tax Risk Assessment System For XHZY Company

In developed countries,tax risk management has become an important part of enterprise risk management.However,in China,tax risk has not received due attention.This phenomenon is closely related to the current situation of China's tax industry which is in the primary stage of development,with the law environment imperfect and the tax collection not rigid enough.Ever since the 18~thh CPC National Congress,a series of major reform measures have been carried out,including the replacement of business tax by value added tax,Gold tax Phase III(tax management by using large data),the land tax merger,the individual tax reform,and the social security transfer tax collection.Major changes are taking place in the mechanisms of Chinese tax system.Tax administration has been developing towards modernization,informatization,and professionalization.Tax risk is further highlighted under this circumstance.XHZY company is a super-large pharmaceutical manufacturing enterprise with high level of management and strong risk control capability which is listed in both Shanghai and Hong Kong.However,members of its administration have never paid due attention to the tax risk management of the company.Recently,there have been major changes in the regulatory and tax policies of the pharmaceutical industry,causing great impact on the original state of the pharmaceutical industry and rapidly accumulating tax risks.Therefore,it is of great urgency to improve the tax risk management ability of the company.The emphasis and difficulty of tax risk management is the tax risk assessment,requiring the proficiency in tax policy,industry characteristics and the status of enterprises.Based on"enterprise risk management--integration with strategy and performance"and"guidance on tax risk management of large enterprises",to recognize,identify,evaluate,and respond to the tax risk,using the tax risk safety checklist and tax risk general identification index,respectively from the perspective of qualitative and quantitative identification of tax risk,determine the tax risk assessment indicators,using the analytic hierarchy process(ahp)to construct the tax risk assessment system,carried out in accordance with the degree of risk probability and impact,XHZY company tax risk score of 71.75 points,belongs to the scope of high risk,In this regard,Suggestions were put forward to include tax risk into the company's overall risk management,cope with tax policy and industry policy adjustment,improve the tax risk assessment system,and improve the tax risk assessment ability and management level of XHZY company.The strategies of tax risk identification and assessment in this thesis are based on current status of the pharmaceutical industry and tax policies,with massive cases of medical industry inspection by tax department.The tax risk assessment model established in this thesis can be good reference to other pharmaceutical manufacturing enterprises.